Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.040 | 14 | 68520282 | intron variant | G/A | snv | 0.90 |
|
Eye Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.040 | 14 | 68520282 | intron variant | G/A | snv | 0.90 |
|
Eye Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.040 | 14 | 68520282 | intron variant | G/A | snv | 0.90 |
|
Eye Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.040 | 14 | 68520282 | intron variant | G/A | snv | 0.90 |
|
Eye Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 14 | 68165095 | intron variant | G/A | snv | 0.89 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68170948 | intron variant | C/A | snv | 0.89 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68177081 | intron variant | G/A | snv | 0.87 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68183059 | intron variant | G/A | snv | 0.87 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68161963 | intron variant | T/C | snv | 0.87 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68193464 | intron variant | A/G | snv | 0.84 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
14 | 68346398 | intron variant | T/C | snv | 0.84 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
14 | 68346398 | intron variant | T/C | snv | 0.84 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
1.000 | 0.080 | 14 | 68166696 | intron variant | G/A | snv | 0.83 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.820 | 1.000 | 6 | 2012 | 2017 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.720 | 1.000 | 3 | 2013 | 2016 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.160 | 14 | 68193711 | intron variant | T/C | snv | 0.80 |
|
Neoplasms; Skin and Connective Tissue Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.120 | 14 | 68301255 | intron variant | G/T | snv | 0.69 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 14 | 68286570 | intron variant | T/G | snv | 0.68 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 14 | 68326837 | intron variant | T/C | snv | 0.68 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 14 | 68595397 | 3 prime UTR variant | C/T | snv | 0.64 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 14 | 68595397 | 3 prime UTR variant | C/T | snv | 0.64 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 14 | 68595397 | 3 prime UTR variant | C/T | snv | 0.64 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 |